PTCT: PTC Therapeutics, Inc.
Performance
PTCT -9.40%
Watchlist
Select an item
Summary
PTCT at a glance
PTCT returned -9.40% over the past year and +9.48% a year over five years. Its worst drop in that year was -33.85%, smaller than 49% of stocks on Redstone, and its Sharpe ratio of -0.10 beats 23% of stocks on Redstone. It pays no dividends.
Current Drawdown
-27.38%
Rolling Volatility
60.73%
Actions
Metrics
Risk Indicators
Alpha-12.43%
Beta0.81x
Sharpe-0.10
Sortino-0.15
Omega0.98
Calmar-0.28
Martin-0.23
Profile
About PTCT
PTC Therapeutics Inc is a biopharmaceutical company that discovers, develops and commercializes clinically differentiated medicines that provide benefits to children and adults living with rare disorders.
- Sector
- Health Care
- Industry
- Pharmaceutical Preparations
- Market cap
- $5.4B
- Listed
- Jun 2013
- Employees
- 991
- Headquarters
- Warren, NJ
- Website
- ptcbio.com
Comparisons